Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein, the leading provider of healthcare solutions, announced the appointment of Mohamad Ali and Deborah Derby to its Board of Directors until the 2021 Annual Meeting. They will stand for re-election at that time. The company also confirmed the retirement of Paul Brons and the non-re-election of Shira Goodman due to other commitments, both of whom have contributed significantly to the company's growth. Ali and Derby bring extensive experience in technology and operational leadership, expected to advance the company's strategic goals.
Henry Schein (Nasdaq: HSIC) will announce its fourth quarter and full-year 2020 financial results on February 17, 2021, before the market opens. A live webcast of the earnings conference call is scheduled for the same day at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Steven Paladino. Investors can access the call through the company's website, with a replay available post-event. Henry Schein, a Fortune 500 company, provides healthcare solutions to dental and medical practitioners globally, reporting sales of $10 billion in 2019.
Henry Schein, Inc. (HSIC) has acquired a majority stake in Prism Medical Products, LLC, a provider of specialty home medical supplies, particularly in advanced wound care. This acquisition expands Henry Schein Medical’s reach into the multibillion-dollar home medical equipment market. Prism, founded in 2006, reported approximately $52 million in net revenue for the year ending September 30, 2020. The acquisition is expected to be neutral to earnings in 2021 and accretive thereafter. PRISM will operate as a subsidiary managed by its founder Chris Cartwright.
Henry Schein (Nasdaq: HSIC) and Casa Schmidt have established a joint venture aimed at enhancing dental practice efficiency in Spain and Portugal. Announced on March 10, 2020, and approved on June 30, 2020, the venture will leverage Henry Schein's extensive solutions portfolio and Casa Schmidt's distribution network, including Schmidt Dental Solutions, Servimed, and specialized implant products. Henry Schein will hold majority ownership, with senior management from both companies. This collaboration is expected to deliver comprehensive, high-quality services to dental professionals in the Iberian market.
Henry Schein, the world’s largest provider of health care solutions for dental and medical practitioners, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 a.m. ET. Investors can access the live webcast via Henry Schein's website, with a replay available afterward. The company has over 19,000 team members and serves more than 1 million customers globally, delivering over 300 solutions to enhance operational success in healthcare.
Henry Schein Medical has announced the availability of Ansell Healthcare's AlphaTec® Model 214 gowns in North America. These non-surgical isolation gowns are made from DuPont™ Tyvek® 1222A fabric, providing superior chemical protection for front-line healthcare workers amid COVID-19. The partnership aims to enhance the accessibility of personal protective equipment (PPE) for healthcare institutions. The gowns feature advanced barrier protection and are available in two sizes, helping fulfill the increasing demand for reliable PPE in the healthcare sector.
Henry Schein Medical has partnered with Yosi Health to enhance patient experiences and streamline administrative processes through Yosi Intake, a digital patient scheduling and registration solution. This collaboration aims to create contactless waiting room experiences, increasing efficiency for healthcare practices. The partnership expands Henry Schein's SolutionsHub, providing a comprehensive suite of customizable solutions that meet the needs of various medical practices and facilities. This partnership is positioned to modernize patient visits while reducing costs and improving overall care quality.
Henry Schein, Inc. (Nasdaq: HSIC) commemorates its 25th anniversary as a public company by opening the Nasdaq Stock Market. The company raised $72.8 million during its IPO in 1995, and has since expanded significantly, achieving $10 billion in sales from continuing operations by 2019. With a market capitalization around $10 billion and over 19,000 employees serving more than one million customers globally, Henry Schein ranks on FORTUNE® magazine’s lists of the World’s Most Admired Companies and the World’s Most Ethical Companies.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
